Empagliflozin Shows Promise for Alleviating Peripheral Diabetic Neuropathy in Type 2 Diabetes Patients: Study Medha Baranwal7 May 2024 10:00 AM ISTEgypt: In a significant development for type 2 diabetes mellitus (T2DM) management, a recent study has uncovered promising evidence regarding the...
Empagliflozin fails to reduce HF hospitalizations, deaths after acute MI: EMPACT-MI Medha Baranwal9 April 2024 10:00 AM ISTUSA: Treatment with empagliflozin did not lead to a significantly reduced risk of first hospitalization for heart failure (HF) or death from any cause...
Exemed Pharmaceutical Gets CDSCO Panel Nod to Study Empagliflozin plus Glimepiride plus Metformin FDC Dr. Divya Colin7 April 2024 5:00 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee SEC functional under the Central Drug Standard Control...
Combination of empagliflozin and citalopram effective against major depressive disorder: Study Medha Baranwal2 April 2024 4:00 AM ISTIran: Combination therapy of empagliflozin and citalopram is effective in reducing symptom severity in patients with major depressive disorder, a...
Zydus Healthcare gets CDSCO Panel Nod To study FDC Empagliflozin plus Metoprolol Succinate Dr. Divya Colin10 March 2024 5:45 PM ISTNew Delhi: The drug major Zydus Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Synokem Pharma Gets CDSCO Panel Nod To Study Antidiabetic FDC Dr. Divya Colin27 Feb 2024 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO approves Jardiance for treatment of adults with chronic kidney disease in India Ruchika Sharma14 Feb 2024 5:49 PM ISTMumbai: The national regulatory authority of India, the Central Drugs Standard Control Organisation (CDSCO), has approved Jardiance...
Diabetes patients taking SGLT2 inhibitors may exhibit false positive urine ethanol tests: NEJM Medha Baranwal9 Feb 2024 11:15 AM ISTUSA: A recent article published in the New England Journal of Medicine described a patient with diabetes who was taking empagliflozin, an SGLT2...
Empagliflozin and semaglutide combination improves glycemic control and BP but not arterial stiffness Jacinthlyn Sylvia1 Feb 2024 10:15 AM ISTA recent 32-week study investigated the effects of empagliflozin, semaglutide, and their combination on vascular function. This study published in the...
Torrent Pharma Gets CDSCO Panel Nod To study antidiabetic FDC Empagliflozin plus Sitagliptin Dr. Divya Colin17 Jan 2024 6:00 PM ISTNew Delhi: The drug major Torrent Pharmaceutical has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Novel aldosterone synthase inhibitor with concurrent empagliflozin reduces albuminuria in CKD patients: Lancet Medha Baranwal16 Jan 2024 7:00 AM ISTUSA: A randomised, controlled, phase 2 trial published in The Lancet has shed light on the safety and efficacy of aldosterone synthase inhibition with...
Empagliflozin may not exhibit clinical or mortality benefit in COVID-19 patients Jacinthlyn Sylvia5 Dec 2023 10:15 AM ISTThe RECOVERY trial has concluded that empagliflozin, a drug proposed for its anti-inflammatory and metabolic effects, does not provide substantial...
